GlassScriptPhysician profile
Corey Lum
NPI 1952668220
$90,053.16
in general payments reported to CMS, 2019-2025
29 companies · $6,003 in 2025
The $6,003 reported for 2025 was more than what a typical Advanced Heart Failure and Transplant Cardiology provider received nationally (typical 2025 total: $1,046).
See the full distribution for Advanced Heart Failure and Transplant Cardiology
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $229 · 2020: $898 · 2021: $4,009 · 2022: $15K · 2023: $40K · 2024: $24K · 2025: $6,003.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program: $51K · Food and Beverage: $9,776 · Travel and Lodging: $5,325 · Consulting Fee: $3,730 · Education: $18.28.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program | $51,486.00 |
| Food and Beverage | $9,775.55 |
| Travel and Lodging | $5,324.81 |
| Consulting Fee | $3,730.00 |
| Education | $18.28 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Boehringer Ingelheim Pharmaceuticals, INC. | $25,443.44 | 2020-2024 | Jardiance |
| Pfizer INC. | $23,077.48 | 2020-2024 | |
| E.R. Squibb & Sons, L.L.C. | $21,138.58 | 2021-2025 | Camzyos |
| Abbott Laboratories | $5,440.64 | 2020-2025 | Cardiomems, Thoratec Heartmate 3 Lvas Implant Kit, 2nd Gen Centrimag Primary Console |
| Alnylam Pharmaceuticals INC. | $5,190.15 | 2021-2025 | Amvuttra, Onpattro |
| Lilly USA, LLC | $1,980.00 | 2022-2024 | Jardiance |
| Abiomed | $1,526.55 | 2022-2025 | Impella |
| Impulse Dynamics (USA) INC. | $997.83 | 2022-2023 | Optimizer |
| Astrazeneca Pharmaceuticals LP | $857.70 | 2022-2025 | Wainua, Farxiga, Dutoprol |
| Boston Scientific Corporation | $821.63 | 2019-2024 | Watchman Flx |
| Merck Sharp & Dohme LLC | $457.98 | 2023-2025 | Verquvo, Winrevair |
| Medtronic, INC. | $344.03 | 2024-2025 | Affera Mapping System, Na, Pulseselect |
| Akcea Therapeutics, INC. | $326.50 | 2020-2021 | |
| Cvrx, INC. | $314.73 | 2021-2023 | Barostim Neo System |
| Novartis Pharmaceuticals Corporation | $285.12 | 2022-2023 |
Show all 29 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Zoll Services LLC (A/K/A Zoll Lifecor Corp) | $284.89 | 2020-2025 | Lifevest |
| Philips North America LLC | $203.79 | 2023-2025 | (5091) Amb Mon & Diag Und, Ambulatory Monitoring & Diagnostics Undivided |
| Ancora Heart, INC. | $197.00 | 2023 | Accucinch |
| Amgen INC. | $194.43 | 2024-2025 | Repatha, Repatha |
| Scpharmaceuticals INC. | $170.42 | 2023 | |
| Atricure, INC. | $155.76 | 2022 | |
| Sobi, INC | $150.00 | 2023 | |
| Bridgebio Pharma, INC. | $148.72 | 2025 | Attruby |
| Actelion Pharmaceuticals US, INC. | $137.63 | 2023-2024 | Uptravi, Opsumit |
| Inspire Medical Systems, INC. | $119.24 | 2025 | Inspire |
| Lantheus Medical Imaging, INC. | $41.24 | 2023-2025 | Definity |
| Bayer Healthcare Pharmaceuticals INC. | $18.28 | 2023 | |
| Endotronix, INC. | $16.19 | 2021 | |
| Amarin Pharma, INC. | $13.21 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Corey Lum listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.